It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GNW’s FA Score shows that 1 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GNW’s TA Score shows that 4 TA indicator(s) are bullish while NEO’s TA Score has 6 bullish TA indicator(s).
GNW (@Life/Health Insurance) experienced а +2.26% price change this week, while NEO (@Medical Specialties) price change was +6.18% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.43%. For the same industry, the average monthly price growth was +6.12%, and the average quarterly price growth was +13.94%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.16%. For the same industry, the average monthly price growth was +16.09%, and the average quarterly price growth was +7.93%.
GNW is expected to report earnings on Nov 05, 2025.
NEO is expected to report earnings on Nov 11, 2025.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
@Medical Specialties (+0.16% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
GNW | NEO | GNW / NEO | |
Capitalization | 3.53B | 865M | 409% |
EBITDA | N/A | -28.47M | - |
Gain YTD | 23.176 | -59.345 | -39% |
P/E Ratio | 17.57 | N/A | - |
Revenue | 7.07B | 689M | 1,026% |
Total Cash | 7.72B | 164M | 4,709% |
Total Debt | 1.52B | 412M | 369% |
GNW | NEO | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 59 Fair valued | |
PROFIT vs RISK RATING 1..100 | 8 | 100 | |
SMR RATING 1..100 | 94 | 94 | |
PRICE GROWTH RATING 1..100 | 42 | 65 | |
P/E GROWTH RATING 1..100 | 98 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NEO's Valuation (59) in the Medical Or Nursing Services industry is in the same range as GNW (64) in the Life Or Health Insurance industry. This means that NEO’s stock grew similarly to GNW’s over the last 12 months.
GNW's Profit vs Risk Rating (8) in the Life Or Health Insurance industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that GNW’s stock grew significantly faster than NEO’s over the last 12 months.
GNW's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as NEO (94) in the Medical Or Nursing Services industry. This means that GNW’s stock grew similarly to NEO’s over the last 12 months.
GNW's Price Growth Rating (42) in the Life Or Health Insurance industry is in the same range as NEO (65) in the Medical Or Nursing Services industry. This means that GNW’s stock grew similarly to NEO’s over the last 12 months.
GNW's P/E Growth Rating (98) in the Life Or Health Insurance industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that GNW’s stock grew similarly to NEO’s over the last 12 months.
GNW | NEO | |
---|---|---|
RSI ODDS (%) | 2 days ago76% | 2 days ago79% |
Stochastic ODDS (%) | 2 days ago63% | 2 days ago80% |
Momentum ODDS (%) | 2 days ago77% | 2 days ago82% |
MACD ODDS (%) | 2 days ago74% | 2 days ago79% |
TrendWeek ODDS (%) | 2 days ago69% | 2 days ago77% |
TrendMonth ODDS (%) | 2 days ago64% | 2 days ago77% |
Advances ODDS (%) | 8 days ago69% | 6 days ago78% |
Declines ODDS (%) | 2 days ago62% | 22 days ago83% |
BollingerBands ODDS (%) | 2 days ago76% | 2 days ago80% |
Aroon ODDS (%) | 2 days ago63% | 2 days ago85% |